Radinate 120｜℞ Artesunate Injection IP 120mg – 10Vial by Gloleaf

Artesunate (ART), a derivative of artemisinin, is one of the artemisinin-based drugs used to treat malaria. It exhibits antiviral, anti-inflammatory, and antitumor properties. For individuals who develop symptoms after receiving two or more doses of vaccines, artesunate currently serves as the only solution. It can eliminate spike proteins from vaccines and viruses, as well as graphene oxide, achieving a 90% cure rate for a variety of life-threatening illnesses. Artesunate is considered safe, has high bioavailability, and combats cancer cells by binding with iron in those cells, releasing free radicals that kill them, while also inhibiting tumor angiogenesis.

Injection Method:

Artesunate as a “Cancer Killer”: Artesunate kills cancer cells by combining with iron within the cells to release free radicals, while also preventing tumor growth. Intravenous administration is well-tolerated, with minimal side effects. However, it may reduce red blood cell counts, so dosage should be carefully monitored, especially in anemic patients.

New Developments in Artesunate as a Cancer Treatment Drug

Clinical Trials:

The World Health Organization (WHO) has selected artesunate for clinical trials in more than 60 hospitals across 52 countries.

Anticancer Efficacy:

Artesunate demonstrates promising responses against multiple cancer types, including:

• Leukemia
• Breast Cancer
• Lung Cancer
• Stomach Cancer
• Liver Cancer
• Bile Duct Cancer
• Ovarian Cancer
• Cervical Cancer
• Endometrial Cancer
• Multiple Myeloma
• Pancreatic Cancer
• Colorectal Cancer
• Brain Cancer
• Prostate Cancer
• Pharyngeal Squamous Cell Carcinoma
• Oral Squamous Cell Carcinoma
• Malignant Melanoma

Clinical Outcomes:

Numerous clinical studies provide evidence supporting its efficacy.

Safety:

Within the normal dosage range, artesunate has almost no side effects.